205 related articles for article (PubMed ID: 30770715)
1. Comorbidities (excluding lymphoma) in Sjögren's syndrome.
Pego-Reigosa JM; Restrepo Vélez J; Baldini C; Rúa-Figueroa Fernández de Larrinoa Í
Rheumatology (Oxford); 2021 May; 60(5):2075-2084. PubMed ID: 30770715
[TBL] [Abstract][Full Text] [Related]
2. Association between comorbidities and extraglandular manifestations in primary Sjögren's syndrome: a multicenter cross-sectional study.
Zhang Y; Li M; Zhang L; Li Q; Yang P; Kong X; Duan X; Zhang M; Li X; Wang Y; Xu J; Wang Y; Hsieh E; Zhao J; Xu D; Zhao Y; Zeng X
Clin Rheumatol; 2020 Sep; 39(9):2677-2688. PubMed ID: 32146615
[TBL] [Abstract][Full Text] [Related]
3. Subclinical atherosclerosis in primary Sjögren's syndrome: comparable risk with diabetes mellitus.
Zhang Y; Luo Q; Lu K; You M; Wang H
Clin Rheumatol; 2023 Jun; 42(6):1607-1614. PubMed ID: 36813944
[TBL] [Abstract][Full Text] [Related]
4. Primary Sjögren's syndrome independently promotes premature subclinical atherosclerosis.
Zehrfeld N; Abelmann M; Benz S; Zippel CL; Beider S; Kramer E; Seeliger T; Sogkas G; Gödecke V; Ahrenstorf G; Armbruster FP; Skripuletz T; Witte T; Derda AA; Sonnenschein K; Ernst D
RMD Open; 2024 Apr; 10(2):. PubMed ID: 38663882
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of subclinical atherosclerosis by ultrasound radiofrequency data technology in patients with primary Sjögren's syndrome.
Ozisler C; Kaplanoglu H
Clin Rheumatol; 2019 Mar; 38(3):709-717. PubMed ID: 30334118
[TBL] [Abstract][Full Text] [Related]
6. Risk of malignancy in Korean patients with primary Sjögren's syndrome.
Kang J; Kim H; Kim J; Choi S; Jung SY; Jang EJ; Cho SK; Sung YK
Int J Rheum Dis; 2020 Aug; 23(9):1240-1247. PubMed ID: 32841507
[TBL] [Abstract][Full Text] [Related]
7. Atherosclerosis in Sjögren's syndrome: evidence, possible mechanisms and knowledge gaps.
Valim V; Gerdts E; Jonsson R; Ferreira GA; Brokstad KA; Brun JG; Midtbø H; Mydel PM
Clin Exp Rheumatol; 2016; 34(1):133-42. PubMed ID: 26812164
[TBL] [Abstract][Full Text] [Related]
8. Primary Sjogren's syndrome and malignancy risk: a systematic review and meta-analysis.
Liang Y; Yang Z; Qin B; Zhong R
Ann Rheum Dis; 2014 Jun; 73(6):1151-6. PubMed ID: 23687261
[TBL] [Abstract][Full Text] [Related]
9. Comorbidities in patients with primary Sjogren's syndrome: a registry-based case-control study.
Kang JH; Lin HC
J Rheumatol; 2010 Jun; 37(6):1188-94. PubMed ID: 20360180
[TBL] [Abstract][Full Text] [Related]
10. Psychological comorbidities associated with subclinical atherosclerosis in Greek patients with primary Sjögren's syndrome: a potential contribution of sleep impairment.
Karageorgas T; Ioakeimidis D; Mavragani CP
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):68-72. PubMed ID: 29148412
[TBL] [Abstract][Full Text] [Related]
11. Incidence of malignancy in primary Sjogren's syndrome in a Chinese cohort.
Zhang W; Feng S; Yan S; Zhao Y; Li M; Sun J; Zhang FC; Cui Q; Dong Y
Rheumatology (Oxford); 2010 Mar; 49(3):571-7. PubMed ID: 20040528
[TBL] [Abstract][Full Text] [Related]
12. Primary Sjögren's Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development.
Goules AV; Argyropoulou OD; Pezoulas VC; Chatzis L; Critselis E; Gandolfo S; Ferro F; Binutti M; Donati V; Zandonella Callegher S; Venetsanopoulou A; Zampeli E; Mavrommati M; Voulgari PV; Exarchos T; Mavragani CP; Baldini C; Skopouli FN; Fotiadis DI; De Vita S; Moutsopoulos HM; Tzioufas AG
Front Immunol; 2020; 11():594096. PubMed ID: 33193443
[TBL] [Abstract][Full Text] [Related]
13. Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity.
Mandl T; Marsal J; Olsson P; Ohlsson B; Andréasson K
Arthritis Res Ther; 2017 Oct; 19(1):237. PubMed ID: 29065905
[TBL] [Abstract][Full Text] [Related]
14. Population-based study of patients with primary Sjögren's syndrome and lymphoma: lymphoma subtypes, clinical characteristics, and gender differences.
Vasaitis L; Nordmark G; Theander E; Backlin C; Smedby KE; Askling J; Rönnblom L; Sundström C; Baecklund E
Scand J Rheumatol; 2020 May; 49(3):225-232. PubMed ID: 32153241
[No Abstract] [Full Text] [Related]
15. Primary Sjögren's syndrome is associated with increased risk of malignancies besides lymphoma: A systematic review and meta-analysis.
Zhong H; Liu S; Wang Y; Xu D; Li M; Zhao Y; Zeng X
Autoimmun Rev; 2022 May; 21(5):103084. PubMed ID: 35341972
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of abnormal ankle brachial index in patients with primary Sjogren's syndrome.
Rachapalli SM; Kiely PD; Bourke BE
Clin Rheumatol; 2009 May; 28(5):587-90. PubMed ID: 19205787
[TBL] [Abstract][Full Text] [Related]
17. Comorbidities in the UK Primary Sjögren's Syndrome Registry.
Tarn J; Lendrem D; Barnes M; Casement J; Ng WF
Front Immunol; 2022; 13():864448. PubMed ID: 35603172
[TBL] [Abstract][Full Text] [Related]
18. Higher risk of dementia in primary Sjogren's syndrome.
Hou TY; Hsu HC; Lin TM; Chang YS; Chen WS; Kuo PI; Lin YC; Chang CC; Chen JH
Ann Clin Transl Neurol; 2019 Apr; 6(4):633-641. PubMed ID: 31019988
[TBL] [Abstract][Full Text] [Related]
19. New parameters for identifying subclinical atherosclerosis in patients with primary Sjögren's syndrome: a pilot study.
Atzeni F; Sarzi-Puttini P; Signorello MC; Gianturco L; Stella D; Boccassini L; Ricci C; Bodini BD; Batticciotto A; De Gennaro-Colonna V; Drago L; Turiel M
Clin Exp Rheumatol; 2014; 32(3):361-8. PubMed ID: 24565029
[TBL] [Abstract][Full Text] [Related]
20. Fibromyalgia prevalence and associated factors in primary Sjögren's syndrome patients in a large cohort from the Spanish Society of Rheumatology registry (SJOGRENSER).
Torrente-Segarra V; Corominas H; Sánchez-Piedra C; Fernández-Castro M; Andreu JL; Martínez-Taboada VM; Olivé A; Rosas J; Sánchez-Alonso F;
Clin Exp Rheumatol; 2017; 35 Suppl 105(3):28-34. PubMed ID: 28240585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
